Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-043279

OCULAR THERAPEUTIX, INC · OCUL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amarpreet Sawhney
Officer — President and CEO · Director · 10% Owner
Period of report
May 13, 2015
Accepted (ET)
May 15, 2015 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 13, 2015M51,491$1.35A538,733D
Common StockF1holding———846,377ISee Footnote
Common StockF2holding———471,784ISee Footnote
Common StockF3holding———379,419ISee Footnote
Common StockF4holding———71,969ISee Footnote
Common StockF5holding———189,393ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F6$1.35May 13, 2015M51,491D—Aug 11, 2016Common Stock51,49158,357D

Explanation of responses